Pharmacokinetic and pharmacodynamic properties of meropenem

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
David P Nicolau

Abstract

Pharmacokinetic and pharmacodynamic profiles of antibiotics are important in determining effective dosing regimens. Although minimum inhibitory concentration (MIC) data reflect microbial susceptibility to an antibiotic, they do not provide dosing information. The integration of pharmacokinetic and microbiological data, however, can be used to design rational dosing strategies. Meropenem is a broad-spectrum beta-lactam antibiotic that penetrates most body fluids and tissues rapidly after intravenous administration. Meropenem undergoes primarily renal elimination; therefore, dosage adjustment is required for patients with renal impairment. Meropenem is indicated for the treatment of complicated skin and skin-structure infections, complicated intra-abdominal infections, and bacterial meningitis. Meropenem has time-dependent bactericidal activity; thus, the percentage of time that free-drug concentrations are higher than the MIC (%T>MIC) best characterizes the drug's pharmacodynamic profile (bactericidal target of approximately 40%T>MIC). Pharmacodynamic modeling can identify regimens with the greatest probability of attaining this target, and probabilities can be compared with clinical and microbiological responses in patients.

References

Jul 1, 1992·Antimicrobial Agents and Chemotherapy·B Ljungberg, I Nilsson-Ehle
Jul 1, 1992·Antimicrobial Agents and Chemotherapy·B A ChristenssonS R Norrby
Jan 1, 1992·European Journal of Clinical Pharmacology·A LeroyG Humbert
Aug 1, 1990·Antimicrobial Agents and Chemotherapy·R WiseJ M Andrews
Aug 1, 1995·Antimicrobial Agents and Chemotherapy·J L BlumerB J Ewing
Jan 1, 1994·Antimicrobial Agents and Chemotherapy·A BedikianM A Gill
May 1, 1993·Antimicrobial Agents and Chemotherapy·A ForrestJ J Schentag
Jul 1, 1995·The Journal of Antimicrobial Chemotherapy·M HutchisonD H Pitkin
Jul 1, 1995·The Journal of Antimicrobial Chemotherapy·S W NewsomH C Kelly
Jul 1, 1995·The Journal of Antimicrobial Chemotherapy·E M ParkerJ L Blumer
Feb 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S GallS Allen
Feb 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R E CondonD Pitkin
Feb 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P T ThyrumK Lasseter
Jun 1, 1997·The Journal of Antimicrobial Chemotherapy·C D FreemanC H Nightingale
Feb 10, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W A Craig
Jul 24, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J D Turnidge
Sep 16, 1998·Antimicrobial Agents and Chemotherapy·F ThalhammerK Ratheiser
Feb 27, 1999·Antimicrobial Agents and Chemotherapy·B BylJ P Thys
Jun 1, 1999·The Journal of Antimicrobial Chemotherapy·F ThalhammerH Burgmann
Aug 15, 2003·The Journal of Antimicrobial Chemotherapy·Sutep Jaruratanasirikul, Somchai Sriwiriyajan
Oct 1, 2003·Journal of Clinical Pharmacology·Joseph L KutiDavid P Nicolau
Mar 20, 2004·Nature Reviews. Microbiology·George L Drusano
Jun 25, 2004·Antimicrobial Agents and Chemotherapy·Joseph L KutiDavid P Nicolau
Oct 13, 2004·Clinical Therapeutics·Holly M MattoesDavid P Nicolau
Dec 16, 2004·The Annals of Pharmacotherapy·Robert E ArianoSheryl A Zelenitsky
Dec 24, 2004·Antimicrobial Agents and Chemotherapy·Dana MaglioDavid P Nicolau
Dec 24, 2004·Antimicrobial Agents and Chemotherapy·Ben M Lomaestro, G L Drusano
Nov 11, 2005·International Journal of Antimicrobial Agents·John E ConteElisabeth Zurlinden
Nov 24, 2005·Antimicrobial Agents and Chemotherapy·Vincent H TamElizabeth A Coyle
Dec 20, 2005·Diagnostic Microbiology and Infectious Disease·Joseph L Kuti, David P Nicolau
Jan 7, 2006·Journal of Clinical Pharmacology·Xiaoli DuDavid P Nicolau

❮ Previous
Next ❯

Citations

Jun 16, 2010·Respirology : Official Journal of the Asian Pacific Society of Respirology·Eric L NuermbergerWing Wai Yew
Jan 6, 2016·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·D NakajimaS Keshavjee
Aug 25, 2011·Current Opinion in Pharmacology·Alasdair MacGowan
Aug 27, 2011·Clinics in Chest Medicine·Seth T HousmanDavid P Nicolau
Nov 26, 2010·Otolaryngologic Clinics of North America·Marilyn E Levi, Vincent D Eusterman
Jan 23, 2010·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Kazuro IkawaMasao Kobayashi
Jan 19, 2010·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Kazuro IkawaKaoru Kurisu
Sep 29, 2009·International Journal of Hygiene and Environmental Health·Alexander VoelzArne Simon
Apr 15, 2015·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Shinji KawanoJunko Kizu
Oct 9, 2015·Hospital Pharmacy·Cristina TomaselloAntonio D'Avolio
Dec 15, 2016·European Journal of Clinical Pharmacology·Muhammad UsmanGeorg Hempel
Jan 20, 2017·Drugs in R&D·Kyle John WilbyAnas Hamad
Mar 28, 2018·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Milan KaskaJirina Martinkova
Feb 15, 2018·Antimicrobial Agents and Chemotherapy·M A ZuurJ W C Alffenaar
Mar 9, 2018·The Annals of Pharmacotherapy·Jonathan C ChoJoe Pardo
Aug 15, 2018·Expert Opinion on Drug Metabolism & Toxicology·Rodrigo M BurgosLarry H Danziger
Apr 29, 2015·Antimicrobial Agents and Chemotherapy·Janus A J HaagensenKatherine Yang
Apr 16, 2014·Antimicrobial Agents and Chemotherapy·S P van RijnJ W C Alffenaar
Oct 30, 2018·Expert Review of Anti-infective Therapy·Owen R AlbinKeith S Kaye
Nov 7, 2018·Antimicrobial Agents and Chemotherapy·David C GriffithMichael N Dudley
Apr 26, 2017·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Jill M Butterfield-Cowper, Kimberli Burgner
Jan 31, 2018·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Malini HattiFredrik Resman
Nov 21, 2018·Antimicrobial Agents and Chemotherapy·Sander P van RijnJan-Willem C Alffenaar
Feb 1, 2018·Critical Care : the Official Journal of the Critical Care Forum·Stephan BrauneClaudia Langebrake
Jan 9, 2016·The European Respiratory Journal·Sander P van RijnJan-Willem C Alffenaar
Mar 19, 2019·Critical Care Medicine·Gianluigi Li BassiAntoni Torres

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Bacterial Meningitis

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Bacterial Meningitis (ASM)

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.